These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19226677)

  • 1. More Kaletra monotherapy results.
    Proj Inf Perspect; 2008 Dec; (47):6-7. PubMed ID: 19226677
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV agents. Using only lopinavir/ritonavir (Kaletra).
    TreatmentUpdate; 2008 Jan; 20(1):1-2. PubMed ID: 18320690
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir.
    TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837
    [No Abstract]   [Full Text] [Related]  

  • 4. Two studies show Kaletra and Isentress similarly suppress HIV, yet have different side effects.
    Proj Inf Perspect; 2009 Mar; (48):6. PubMed ID: 19492458
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HIV agents. Once-daily lopinavir/ritonavir (Kaletra).
    TreatmentUpdate; 2004 Mar; 16(2):3-4. PubMed ID: 17219667
    [No Abstract]   [Full Text] [Related]  

  • 6. LPV monotherapy: 72-week data.
    IAPAC Mon; 2006 Jan; 12(1):9. PubMed ID: 17252624
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HIV agents. A trial of Kaletra monotherapy.
    TreatmentUpdate; 2008 Jan; 20(1):2-3. PubMed ID: 18320691
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HIV agents. Kaletra and Meltrex update.
    TreatmentUpdate; 2005; 17(5):4-5. PubMed ID: 17225278
    [No Abstract]   [Full Text] [Related]  

  • 9. Prezista fares better than Kaletra in first line therapy.
    Proj Inf Perspect; 2009 Mar; (48):7-8. PubMed ID: 19492459
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-HIV agents. Lopinavir--results after one year.
    TreatmentUpdate; 2001; 12(8):1-2. PubMed ID: 12132436
    [No Abstract]   [Full Text] [Related]  

  • 11. The state of access to Kaletra.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):4-5. PubMed ID: 17228448
    [No Abstract]   [Full Text] [Related]  

  • 12. Kaletra single agent HAART after intolerance of NRTI- and NNRTI-containing regimens following kidney transplantation.
    Schürmann D; Wesselmann H; Kurowski M; Suttorp N; Reinke P
    Infection; 2007 Jun; 35(3):194-6. PubMed ID: 17565464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABT-378/r helpful in failing patients.
    AIDS Patient Care STDS; 2000 May; 14(5):281-2. PubMed ID: 10833817
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. FDA approves half-strength Kaletra.
    AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug interactions. Coming soon--a new formulation of Kaletra.
    TreatmentUpdate; 2006; 18(3):7. PubMed ID: 17209241
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA notifications. Abbott sends out provider letter about Kaletra for kids.
    AIDS Alert; 2007 Oct; 22(10):118. PubMed ID: 18416010
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HIV agents. Lopinavir and ritonavir (Kaletra) tablets get tested.
    TreatmentUpdate; 2008 Mar; 20(2):5-6. PubMed ID: 18661644
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. Kaletra revisions to packaging approved.
    AIDS Alert; 2010 Mar; 25(3):34. PubMed ID: 20629261
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninferiority and lopinavir/ritonavir monotherapy trials.
    Pulido F; Arribas JR
    AIDS; 2008 Aug; 22(13):1696-7. PubMed ID: 18670240
    [No Abstract]   [Full Text] [Related]  

  • 20. Kaletra monotherapy controversy: AmfAR publishes overview.
    AIDS Treat News; 2004 Sep; (405):7. PubMed ID: 15595152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.